A large fraction of transcripts are expressed antisense to introns of known genes in the human genome. Here we show the construction and use of a cDNA microarray platform enriched in intronic transcripts to assess their biological relevance in pathological conditions. To validate the approach, prostate cancer was used as a model, and 27 patient tumor samples with Gleason scores ranging from 5 to 10 were analyzed. We find that a considerably higher fraction (6.6%, [23/346]) of intronic transcripts are significantly correlated (Pp0.001) to the degree of prostate tumor differentiation (Gleason score) when compared to transcripts from unannotated genomic regions (1%, [6/539]) or from exons of known genes (2%, [27/1369]). Among the top twelve transcripts most correlated to tumor differentiation, six are antisense intronic messages as shown by orientation-specific RT-PCR or Northern blot analysis with strand-specific riboprobe. Orientation-specific real-time RT-PCR with six tumor samples, confirmed the correlation (P ¼ 0.024) between the low/high degrees of tumor differentiation and antisense intronic RASSF1 transcript levels. The need to use intron arrays to reveal the transcriptome profile of antisense intronic RNA in cancer has clearly emerged.
Introduction
Microarray technology has permitted a refined highthroughput mapping of the transcriptional activity in the human genome (Shoemaker et al., 2001; Kapranov et al., 2002; Rinn et al., 2003; Kampa et al., 2004) , revealing a two-to ten-fold excess of transcripts along chromosome 22 (Kapranov et al., 2002; Rinn et al., 2003) than originally predicted by mapping of known genes (Lander et al., 2001; Venter et al., 2001) . Using microarrays that probed the genomic DNA along all the extension of chromosomes 21 and 22, an approach that is essentially not biased towards the coding regions, comparable fractions of transcriptional activity were detected within exons or introns of annotated genes, and nearly half of these intronic transcripts were expressed antisense to their respective well-characterized introns (Rinn et al., 2003; Kampa et al., 2004) . In other recent work, widespread occurrence of antisense transcription in the human genome has been detected (Shendure and Church, 2002; Yelin et al., 2003) . However, intronic non-spliced transcripts were not appreciated in these latter reports, because the authors either selected transcripts with evidence of splicing (Shendure and Church, 2002) or pairs of sense-antisense messages for which at least one exon was collinear on the genome sequence (Yelin et al., 2003) . In fact, large-scale transcription profiling has mainly been performed with exon arrays, which rely on the annotations of the human genome to choose which genomic protein-coding regions to sample.
Our goal was to study the transcriptional profile of intronic messages in cancer, using prostate tumors with different degrees of differentiation as a model. Therefore, we constructed a cDNA microarray that is enriched with a collection of partial transcripts that map to intronic segments of known genes. We used a bioinformatics approach to select these from nearly one million ESTs that were generated by the Human Cancer Genome Project with the ORESTES technique (DiasNeto et al., 2000) from 24 distinct types of cancer and normal adjacent tissues, having sampled over 60% of the human genes (Camargo et al., 2001; Brentani et al., 2003) . The resulting intron array was used to measure the expression profile of 27 prostate tumor samples with different degrees of differentiation (Gleason score, GS 5 to 10). Our results show that a considerable fraction of tumor-correlated genes are intronic fragments, pointing to the biological relevance of these messages in complex diseases such as cancer.
Results

Construction of an intron array
To identify a set of intronic transcripts represented in the public human EST databases that could be used for the construction of an intron array, we have compared the relative genome mapping coordinates of ORESTES reads with those from a curated set of known human transcripts (see Materials and Methods section for details). We found 150 236 unspliced ORESTES that were totally contained within 37 899 unique intronic regions of well-annotated human genes (RefSeq) ( Table 1 ) and 136 628 ORESTES that mapped to 45 400 unannotated genomic regions. From these sets, we randomly sampled 619 and 1019 clones, respectively, representing 2% of each of these unique genomic regions, to be deposited in our cDNA microarray. In addition, 2048 gene fragments were selected representing known exons of RefSeq genes previously described as involved in cancer.
Intronic transcripts are expressed in prostate
To verify which fraction of these putative novel transcripts was expressed in prostate, we have measured their abundance by microarray hybridization with poly(A) þ mRNA from tumor and normal adjacent tissues from 27 patients. As shown in Table 1 , we detected expression of comparable fractions of transcripts that mapped to intronic regions of RefSeq, to unannotated regions of the human genome, and to known exons of RefSeq genes. Finding that most of the unspliced transcripts that are totally contained in introns were expressed in prostate (Table 1) strongly argues against a conservative approach of ab initio excluding from a transcriptome analysis the intronic unspliced messages as putative contaminants (Sorek and Safer, 2003) . It is apparent that screening of the human transcriptome for diseases with commercial exon microarrays, primarily containing messages of previously characterized full-length genes, does not address the possible change in the levels of intronic messages with putative regulatory roles in pathological conditions. Non-coding intronic transcript levels correlate to the degree of prostate tumor differentiation
To search for intronic and novel transcripts whose expression would correlate to the degree of tumor differentiation (GS), we analyzed the expression profile of the 27 prostate tumor samples with different GS from 5 to 10. A Self-Organizing Map and an unsupervised hierarchical clustering analysis revealed that all high-GS (9 and 10) samples clustered together, indicating that a distinct expression profile of high-GS tumors was present (Figures 1a, b) . Bootstrap resampling was used to confirm that grouping of high-GS samples in the hierarchical clustering analysis is extremely robust (Figure 1b) . In fact, recent reports have identified genes that are strongly correlated with the tumor GS in prostate cancer (Singh et al., 2002; Best et al., 2003; Lapointe et al., 2004) . We then used Pearson correlation and bootstrapping to identify messages significantly correlated to GS among the low-(5 and 6) and high-GS samples. We identified a classifier set of 56 genes for which the expression level was significantly correlated (P-valuep0.001) to the low-/high-GS class distinction ( Figure 2a ). We found that within this set, 27 are known exons of RefSeq genes, 23 are intronic transcripts and 6 are ESTs that map to unannotated genomic sequence.
A cross-validation leave-one-out procedure was used to evaluate the robustness of the low-/high-GS gene classifier. Genes that appear in at least 60% of the classifiers are listed in Figures 2b and c 'Total in the collection' refers to the number of clones in the collection generated by the Human Cancer Genome Project (Dias-Neto et al., 2000) . 'Expressed in prostate' refers to the gene fragments whose background-subtracted intensities were at least 3 s.d. above the average microarray slide background intensity in at least 5 prostate samples (out of 47). The percentage of expressed fragments with respect to the total number of fragments of that category in the microarray is indicated in parenthesis.
of these, EIF4E, TMEPA1 and RNF139, have been associated with progression of different types of cancer (Gemmill et al., 1998; Brunschwig et al., 2003; Ramaswamy et al., 2003) .
When the low-/high-GS classifier was applied to the expression profile of sixteen intermediate-grade GS 7 tumor samples, using a supervised method (van 't Veer et al., 2002) , two groups of patients were identified ( Figure 3 ). Thus, while most of the GS 7 tumor samples exhibited a positive correlation to the average expression profile of the low-GS tumors, four GS 7 samples (patients 17, 19, 47 and 3) were identified that are negatively correlated to the low-GS profile. These results are in line with the fact that patients with intermediategrade GS 7 tumors have a heterogeneous clinical outcome (Epstein et al., 1996) .
Characterization of cancer-related intronic transcripts
To characterize the seven predicted intronic transcripts identified by the low-/high-GS gene classifier, we performed orientation-specific reverse transcription (RT) followed by PCR, which showed that six of these were transcribed antisense to the corresponding intron ( Figure 2d ). Interestingly, we found that for these six genes an intronic sense message overlapping the intronic antisense sequence was also present in the mRNA sample ( Figure 2d ). The implications of this finding will be discussed below.
We found that the remaining predicted intronic message was not expressed antisense, but rather it is a novel exon of TLE3 (Figure 4a ), a member of the Notch signaling pathway involved in epithelial differentiation (Liu et al., 1996) . Northern blot showed a 5.53 kbp band, which is compatible with a full-length alternatively spliced TLE3 transcript ( Figure 4b ). The additional exon introduces an early stop codon that truncates TLE carboxyl-terminal WD-40 domain and leaves its amino-terminal Q-rich domain; these truncated forms are expressed by most metazoans and may negatively regulate full-length TLE proteins, perhaps by sequestering them in non-productive complexes (Chen and Courey, 2000) .
We used RACE-PCR and/or strand-specific Northern blot to confirm the orientation of three out of the six correlated intronic messages. RACE-PCR determined that they were 0.6 to 1.1 kbp long transcripts that mapped to introns of different genes in different We used mRNA from DU145 prostate tumor cell line to perform orientation-specific reverse transcription ( þ RT) using either an antisense or a sense specific primer, followed by PCR using a nested pair of primers for an amplicon within the intronic region of each indicated gene. Controls omitting either the reverse transcriptase (À RT/ þ primer) or omitting the primer during reverse transcription ( þ RT/À primer) were performed. An additional control is shown for an amplicon within a known exon of TMEPA1, where only the sense transcript was detected Figure 3 Expression levels of the 56 correlated genes measured on intermediate-grade (GS 7) tumor samples. Left panel shows the expression matrix of 56 genes correlated to the low-/high-Gleason score (GS) class distinction that were identified in the experiment described in Figure 2a . Genes (columns) are ordered by their Pearson correlation. Sixteen GS-7 patient samples were analyzed (rows) and they are ordered by their correlation (r) to the low-GS profile, which is shown in the right panel. Intronic gene fragments have their names in blue. Expression level of each gene is represented by the number of standard deviations above (red) or below (blue) the average value for that gene across all samples chromosomes (Figures 4c, e and g, yellow bars) . Interestingly, these are unspliced messages that do not have coding potential, as determined by ESTScan (Iseli et al., 1999) . For RASSF1 and AP1GBP1, an orientation-specific RACE-PCR further verified the presence of an antisense message (Figures 4c and g, red arrows) . Antisense orientation of RASSF1and PPHLN1 was confirmed by strand-specific Northern blot (Figures 4d  and f) . RACE-PCR products of the remaining 3 intronic transcripts did not extend the ORESTES cDNA clones with the libraries used.
Validation by Real-Time PCR of down-regulation of RASSF1 intronic antisense messages Double-stranded cDNA microarrays are unable to discriminate between sense and antisense overlapping messages. Thus, finding differential levels of expression in overlapping intronic transcripts can reflect a change in either one or in both messages. To discriminate between the two possibilities, we used quantitative orientation-specific real-time RT-PCR to confirm the differential expression of RASSF1, the most correlated intronic transcript. Figure 5a shows that both antisense and sense intronic transcripts are significantly downregulated in high-GS as compared to low-GS tumor samples (P-values ¼ 0.024 and ¼ 0.014, respectively). RASSF1 hypermethylation correlates with the GS of prostate tumors (Liu et al., 2002) . In line with that, we show here that RASSF1 protein-encoding exonic transcripts are significantly down-regulated in high-GS tumor samples (P-value ¼ 0.009) (Figure 5b ). We also confirmed in the experiment of Figure 5c that RASSF1 protein-encoding exonic transcript level is lower (Pvalue ¼ 0.002) in GS 7 tumors whose expression profiles in the microarray were found to be negatively correlated with the average low-GS pattern (patients 17, 19, 47 and 3) (see Figure 3) .
Discussion
Our microarray expression study suggests that the majority of the over 37 000 unique intronic regions of known genes, which were mapped by ORESTES sequences throughout the chromosomes, have indeed transcriptional activity. This adds to the finding of significant intronic transcriptional activities mapped to chromosomes 21 and 22 (Kapranov et al., 2002; Rinn et al., 2003; Kampa et al., 2004) . Our finding of unspliced long antisense intronic RNAs is in agreement with the recent report of 0.4-1.3 kbp unspliced antisense totally intronic RNAs in chromosome 22 (Rinn et al., 2003) .
We simultaneously detected in a poly(A) þ RNA sample the presence of antisense and sense pairs of overlapping intronic transcripts that are correlated to the degree of tumor differentiation and map to 6 different genomic loci. Totally intronic antisense transcripts would have to target their complementary intronic sense message (in pre-mRNA) to play a regulatory role in processing protein-encoding RNA messages. Similarly, totally intronic antisense messages have been detected by a genome-wide mapping analysis in mice (Kiyosawa et al., 2003) . Antisense RNA transcripts have been previously implicated with imprinting and X-chromosome inactivation (Lee et al., 1999; Sleutels et al., 2000) . Antisense RNA has also been shown to mediate gene silencing and methylation in alpha-thalassemia, a genetic autosomal disease (Tufarelli et al., 2003) . Moreover, some antisense intronic transcripts have been shown to act as negative effectors of the cancer-related genes cMyc (Nepveu and Marcu, 1986) and p53 (Khochbin and Lawrence, 1989) and as positive effector of RPS14 gene transcription (Tasheva and Roufa, 1995) . We speculate that sense/ antisense intronic transcript pairs may be part of a general regulatory mechanism of gene expression not yet fully appreciated in eukaryotes. In fact, a recent unbiased mapping of transcription factor binding sites along chromosomes 21 and 22 revealed that 36% of the binding sites for Sp1, cMyc and p53 are significantly correlated with non-coding RNAs, and overlapping pairs of protein-coding and non-coding RNAs are often co-regulated (Cawley et al., 2004) .
Both sense and antisense intronic transcript levels of RASSF1 were diminished in high-GS tumors. In fact, by analyzing the fraction of tumor-correlated genes with Figure 5 RASSF1 expression is down regulated in high-GS tumors. Orientation-specific reverse transcription followed by Real-time quantitative PCR was used for the measurement of mRNA levels. Relative fractions were calculated with respect to the average mRNA level across all samples. (a) Antisense (dashed bars) and sense (full bars) RASSF1 intronic transcript levels were measured in 3 low-(grey bars) and 3 high-(black bars) GS tumor samples. (b) Protein-encoding RASSF1 exonic transcript levels, measured as in a. (c) Protein-encoding RASSF1 exonic transcript levels measured in GS 7 tumor samples that were either negatively correlated (black bars) or positively correlated (grey bars) to the average low-GS expression profile in the microarray experiments of Figure 3 . Standard error bars from 3 replicate experiments are shown in a-c respect to all genes expressed in prostate, we observed a considerably higher fraction of intronic transcripts (6.6%, [23/346] ) when compared to transcripts mapping to unannotated genomic regions (1%, [6/539]) or to exons of RefSeq genes (2%, [27/1,369]). As evidence is continuing to accumulate that the transcriptional output of the human genome is far more complex then anticipated, so are the questions as to the biological relevance of these novel and apparently non-coding transcripts. Correlation with a stage of tumor progression argues that such transcripts are not just random biological noise. This finding argues for inclusion of probes to such non-coding transcripts, both intra-and inter-genic, into the arsenal of tools used for molecular diagnostics, so far almost exclusively populated by assays of protein-coding transcripts.
A paradigm in oncogenesis is the accumulation of mutations in the open reading frames of proteinencoding oncogenes and tumor suppressors (McManus, 2003) . The implication in cancer of various classes of non-coding RNAs such as microRNAs (McManus, 2003; Calin et al., 2004 ) is becoming evident. We suggest that identification of antisense intronic RNAs correlated to cancer, such as those described here, will likely increase the complexity of the current paradigm.
Materials and methods
Microarray construction
A bioinformatics approach was used to select partial transcripts that map to intronic segments of known genes. The initial sequence dataset contained 1 187 342 ORESTES cDNAs that were generated by the Human Cancer Genome Project with the ORESTES technique (Dias-Neto et al., 2000) . 956 456 filtered ORESTES and 20 793 RefSeq sequences were aligned to the genome sequence (UCSC draft HG12 Jun2002) using BLAT. Genomic coordinates of each ORESTES were compared to the exon/intron genomic coordinates of all RefSeq sequences and three categories were defined: 1) ORESTES that were collinear to a RefSeq and had at least 5 bases overlapping a known exon were annotated as known exons of RefSeq genes; 2) those that were collinear to a RefSeq and did not overlap any known exon were annotated as mapping to introns of RefSeq genes; 3) ORESTES non-collinear to RefSeq and with no match to full-length or partial mRNAs from GenBank were categorized as mapping to unannotated genomic regions. Within each of these categories we determined the number of unique genomic regions to which the ORESTES were mapped by merging overlapping sequences. Glass-slides were constructed containing 3686 cDNA fragments in duplicate, in a 9216 elements microarray, using Amersham Biosciences Generation III microarray system. Detailed information including cDNA amplification is available in the Supplementary Materials and methods available online.
Patient samples and target labeling
Samples of prostate tumor were obtained from freshly-frozen tissue collections with informed consent from patients submitted to radical prostatectomy and were snap-frozen in liquid nitrogen within 10 min from resection. Each sample was reviewed by a pathologist for determination of the degree of tumor differentiation, which is measured by the Gleason score (GS) of the tumor (Gleason, 1977) . Prior to RNA extraction, samples were re-examined and hematoxylin/eosin stained micro-sections obtained from each side of the frozen blocks were used to grossly delimit the spatial distribution of the tumor mass. If necessary, tissue blocks were further dissected to warrant that at least 70% of the section used for RNA extraction was composed of malignant cells. Macro-dissected tumor samples were returned to liquid nitrogen until use. Poly(A) þ RNA was isolated using mMACS mRNA isolation kit (Miltenyi Biotec). Each sample was labeled in parallel with either Cy3-or Cy5-labelled nucleotides (CyScribe first-strand cDNA labeling kit, Amersham Biosciences) using 1 mg mRNA and a mixture of oligo-dT and 9-mer random oligonucleotides. Control experiments with DNAse-treated samples performed in parallel showed that some contaminant genomic DNA was labeled at a minor extent, as analyzed by the ratio of exon/ (intron þ unannotated) fragments that are detected in the microarray (see Supplementary Materials and Methods). The fraction of intronic or unannotated transcripts expressed in prostate might be overestimated by a maximum of 11% due to this contaminant. If present, genomic DNA contamination is expected to be randomly distributed across all genes in all samples. Therefore no particular gene is expected to be identified as statistically correlated to tumor differentiation in the analyses due to this contamination. Correlated intronic messages detected in the microarray experiments were further validated by strand-specific RT-PCR, RACE-PCR and/or strand-specific Northern blot (see below). Microarray data acquisition and processing is described under Supplementary Materials and Methods available online.
Statistical analyses
Unsupervised clustering of the data was performed either with Self-organizing map using the GeneCluster2 analysis package (Tamayo et al., 1999) or with Hierarchical clustering (SanchezCarbayo et al., 2002) , using Euclidean distance metric and Ward linkage. We assessed the robustness of the unsupervised clustering analysis by a bootstrap resampling technique (Sanchez-Carbayo et al., 2002) . This was used to generate 10 000 copies of the data set by adding Gaussian noise to the original data, as described in detail in the Supplementary Materials and Methods available online. A consensus tree was constructed by finding for each node the pairing that occurred most often in the 10 000 separate trials. A graph was constructed that displays this count at each node of the tree. Nodes with values closer to 10 000 are more robust than with lower ones. A supervised selection of genes whose expression is significantly correlated to tumor GS score classes was performed as previously described by Singh et al. (2002) using Pearson correlation analysis. Statistical significance was ascertained by re-calculating the correlation following 50 000 random permutations of GS sample labels and computing the frequency at which the correlation measured in the original set was observed in the randomly permuted data. The amount of significantly correlated genes (with P-valuep0.001) exceeds by eight-fold the number of genes expected to be found by chance alone in the dataset using the same confidence interval (7 genes in a two-tailed distribution). Robustness of the low-/high-GS gene classifier was evaluated by patient leave-one-out crossvalidation (Singh et al., 2002) . Essentially one patient is removed and a new set of significantly correlated genes (Pvaluep0.001) is determined using the remainder samples. This procedure was repeated for each one of the 11 patient samples and correlated genes were ordered by the frequency at which they appear in the various sets thus identifying the most robust classifiers.
Orientation-specific RT-PCR and RACE-PCR
For orientation-specific RT-PCR 0.5 mg. poly(A)
þ RNA was treated with 1 U Promega RQ1 RNAse-free DNAse for 30-60 min at 371C in a 15 ml volume in the presence of 20 U RNasin ribonuclease inhibitor (Promega). DNAse was inactivated at 651C for 10 min and the sample was kept at 501C. cDNA was generated at 501C for 45-60 min in a 50 ml volume using 100 ng of mRNA, 200 units of SuperscriptII reverse transcriptase (Invitrogen) plus 0.36-0.9 mM of a specific primer for either the sense or the antisense strand of each intronic region (Cawley et al., 2004; Shendure and Church, 2002) . The reverse transcription primer mapped within 30 to 60 bp upstream from the target intronic segment of the RNA to be reverse transcribed. Controls for the absence of self-priming were done with reverse transcriptase in the absence of primers, and controls for the absence of DNA were done by incubation with primers and no reverse transcriptase. A control with a primer complementary to the coding region of beta-tubulin was done in parallel. The sample was heated for 30 min at 961C to denature the reverse transcriptase and one pair of primers for PCR amplification of either the beta-tubulin gene or the desired target intronic segment under study were added; reactions were carried out for 40 cycles in a volume of 20 ml and according to the manufacturer's instructions for SybrGreen PCR Core Reagent using the GenAmp 5700 Sequence Detector (Applied Biosystems). For RACE-PCR we used commercial cDNA libraries prepared from lung (cat. 7445-1) and colon (cat. HL3014B) poly(A) þ RNA respectively (BD Bioscences -Palo Alto, CA). The colon cDNA library is directionally ligated into a lambda gt11 vector, which allows the determination of the orientation of cloned transcripts. RACE-PCR was performed with Taq DNA Polymerase (Bioline -Canton, MA). Additional details are available as Supplementary Materials and Methods available online.
Accession numbers
TLE3, AY566265; antisense RASSF1, AY545527 and AY545528; antisense PPHLN1, AY545526; antisense AP1GBP1, AY545524 and AY545525.
Abbreviations GS, Gleason score.
